Macrolide-resistant Streptococcus pneumoniae in canada during 1998-1999: Prevalence of mef(A) and erm(B) and susceptibilities to ketolides

Antimicrobial Agents and Chemotherapy

Volumn 45, Issue 7, 2001, Pages 2147-2150

  Hoban, D J ^a   Wierzbowski, A K ^a   Nichol, K ^a   Zhanel, G G ^a  

^a HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CETHROMYCIN; KETOLIDE; MACROLIDE; TELITHROMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENETICS; BACTERIUM ISOLATE; CANADA; CROSS RESISTANCE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; CANADA; DRUG RESISTANCE, MICROBIAL; ERYTHROMYCIN; GENE FREQUENCY; HUMANS; KETOLIDES; MACROLIDES; MEMBRANE PROTEINS; METHYLTRANSFERASES; MICROBIAL SENSITIVITY TESTS; STREPTOCOCCUS PNEUMONIAE;

EID: 0034956121     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.45.7.2147-2150.2001     Document Type: Article

References (27)

1. Pneumococcal macrolide resistance: Myth or reality?
2. Evolving resistance patterns of S. pneumoniae: A link with long-acting macrolide consumption?
3. Antimicrobial resistance of 1,113 Streptococcus pneumoniae isolates from patients with respiratory tract infections in Spain: Results of 1-year (1996-1997) multi-center surveillance study. The Spanish Surveillance Group for Respiratory Pathogens
4. In vitro activity of ABT-773, a new ketolide, against recent clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis
5. Antibiotic use in a Canadian province 1995-1998
6. Clinical significance of resistant organisms in otitis media
7. In vitro development of resistance to telithromycin (HMR 3647), four macrolides, clindamycin, and pristinamycin in Streptococcus pneumoniae
8. Antipneumococcal activity of ABT-773 compared to those of 10 other agents
9. Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: 1997 Results from the SENTRY Antimicrobial Surveillance Program
10. A multicentre collaborative study of the antimicrobial susceptibility of community acquired lower respiratory tract pathogens
11. The new antibacterial class: The ketolides
12. In vitro activity of the novel ketolide HMR 3647 and comparative oral antibiotics against Canadian respiratory isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis
13. Prevalence and characterization of the mechanisms of macrolide, lincosamide, and streptogramin resistance in isolates of Streptococcus pneumoniae
14. Breakthrough pneumococcal bacteremia in patients being treated with azithromycin and clarithromycin
15. Clinical implications of antibiotic resistance for management of acute otitis media
16. Increased activity of 16-membered lactone ring macrolides against erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae: Characterization of South African isolates
17. Nomenclature for macrolide and macrolide-lincosamide -streptogramin B resistance determinants
18. Characterization of a genetic element carrying the IV efflux gene mefA in Streptococcus pneumoniae
19. Prevalence of macrolide resistance mechanisms in Streptococcus pneumoniae isolates from a multicenter antibiotic resistance surveillance study conducted in the United States in 1994-1995
20. Streptococcus pneurnoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: A common resistance pattern mediated by an cfflux system
21. Use of clindamycin disks to detect maerolide resistance mediated by erm(B)erm(B) and mefE in Streptococcus pneumoniae isolates from adults and children
22. Introduction: The role of bacterial infection in chronic bronchitis
23. Review of macrolides/ketolides: Focus on respiratory infections
24. Prevalence of antimicrobial resistance in respiratory tract isolates of Streptococcus pneumoniae: Results of a Canadian national surveillance study
25. Induction of ribosome methylation in MLS-resistant Streptococcus pneumoniae by macrolides and ketolides